Insight Molecular Diagnostics, Inc. - IMDX Net earnings per share for the last four quarters
Insight Molecular Diagnostics (IMDX) efficiency relies on the rapid transport of biomaterials to laboratories for accurate diagnoses. However, profitability is constrained by strict insurance tariffs, forcing the company to scale its service volumes. Risks are tied to regulatory approvals and competition, while EPS stands at 57.00. This price chart on GURU.Markets, which assists in the asset's baseline valuation, clearly demonstrates the dynamics of this business within the molecular research sector.
IMDX (Insight Molecular): analytical breakdowns and indicator data
- market price and analyst price targets:
- issuer market value details:
- book value of equity indicators:
- debt and liquidity data:
Debt to Equity Ratio Insight Molecular Diagnostics|IMDX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Insight Molecular Diagnostics|IMDX - Company Aggregate Debts|Debts to Net Assets Insight Molecular Diagnostics, Inc.|IMDX - Company Long-Term Debts|Short-Term Indebtedness Insight Molecular Diagnostics|Intermediate Coverage Ratio imdxinc.com
- business earnings and investment ratios data:
IMDX - Net Income|Future Net Profit Insight Molecular Diagnostics|IMDX - Price to Earnings Ratio|Future Price to Earnings Multiple Insight Molecular Diagnostics|IMDX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Insight Molecular Diagnostics, Inc.|IMDX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Insight Molecular Diagnostics|IMDX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months imdxinc.com|IMDX - Earnings growth in current year|Expected net earnings per share growth next year Insight Molecular Diagnostics
- sales and revenue indicators:
Fundamental company valuation:IMDX (Insight Molecular Diagnostics Inc)
This metric measures the rolling year net income per share trend, allowing for an assessment of real capital generation efficiency regardless of market volatility. Analyzing the annual EPS growth rate over the last 12 months serves as a stress-testing tool for Insight Molecular Diagnostics (IMDX) assets, confirming the company's ability to monetize clinic demand for high-precision molecular diagnostics and specialized equipment.
Competitor analysis for Insight Molecular Diagnostics
Net earnings per share for the last four quarters agilent.com A|DGX: Net earnings per share (EPS TTM)|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share for the last four quarters anbio.com|Earnings per share for the last twelve months Sotera Health SHC|QDEL: Earnings per share for the last 12 months|OPK - Earnings per share for the last twelve months|Net earnings per share for the last four quarters CareDx, Inc CDNA|MRVI: Net earnings per share (EPS TTM)|FLGT - Net earnings per share for the last four quarters|LAB (Standard BioTools) - Net earnings per share (EPS TTM)|CTKB - Net earnings per share for the trailing year|Net earnings per share (EPS TTM) OSUR|XGN (exagen.com) - Earnings per share for the trailing year|MDxHealth SA - Net earnings per share for the last 12 months|Earnings per share for the last four quarters LUCD (luciddx.com)|PRE: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (Trinity Biotech plc)|ProPhase (PRPH) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Ainos Corporation|Earnings per share for the last twelve months Co-Diagnostics, Inc.|Net earnings per one share for the last twelve months heartsciences.com HSCS|Earnings per share for the last twelve months Biomerica (BMRA)|Earnings per share for the last twelve months CDIO (cardiodiagnosticsinc.com)|Net earnings per share (EPS TTM) ONCO (Onconetix Corp)|Virax Biolabs Corp (VRAX) - Net earnings per one share for the last twelve months|Bluejay Diagnostics - Net earnings per share (EPS TTM)|aspirawh.com (AWH) - Net earnings per share for the last 12 months|AXDX (Accelerate Diagnostics, Inc.) - Net earnings per share for the last 12 months|centogene.com (CNTG) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Enzo Biochem Inc.|Earnings per share for the last twelve months FRES|Net earnings per share (EPS TTM) GENE|Net earnings per share (EPS TTM) 23andme.com (ME)|Earnings per share for the last twelve months Psychemedics Corporation PMD
